{"name":"Beam Therapeutics Inc.","slug":"beam-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPcUNUUXNwaHV4WS1Za1FaWE5kOWREbG8yWDU3TzRJQVR1Z0JBOElqbXhUcDlGUXJLWmNWLTJ4VWNMV3lRTmRVN1JfUlJ2Wnp2ODVXZTZ4c2kyNzlxdHJyZXFibnV5TEo1bVZXTTZoNUYwTGVLWVFCVC1jbGVxXy04WjlKLWxjTF82M1pkLU1vdHBRNzlKWkVPOE9NMjF4VTZsM2p5NklVT2JaYUlvdm5oNzQwRkc5Qkw0aVdZTzBTRlQ5QjZyNS1yemFmR09FejZReDh6OG1hMkpFazRLMDZzbTY1WmZpQ01xMV9td3JFSjhmdndIemRBRWpPLXhGbTBNX1NIc29BT1dBa2dDMEdJbHNvZ3g2QWstdFptU2RMX05jYklzTVdEWDVLdFZQYk5UX2lJMkhWNkpJMGxD?oc=5","date":"2026-03-27","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM), KalVista Pharmaceuticals (KALV) and Ionis Pharmaceuticals (IONS) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM), KalVista Pharmaceuticals (KALV) and Ionis Pha","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNSUNkT2dHVnlCOGhDODgycHNMYXktSzRfYXdwUHVvZU02dDhEUzJTMmNLbWtUM3BzQTVpR3VFU2FzMjJLcW1VMHlCS1MwaGtJU0ZIX3lvUnlxRE5Oa09GdmtPNkMyalQ4Z0lSNWtDYkhILUdFR2syOXBYQ3RWNldJUVpPYk1CdlJqZkNXZWIyQ0cySEhkR1dsRTROUFJYd2ZWMGpqTER4blRzWWJoN3ZFMTN1cHlvU1llN2J2eVY0Uy10VThQZi1peGRIak1YcmZxRlE?oc=5","date":"2026-03-26","type":"pipeline","source":"The Globe and Mail","summary":"Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail","headline":"Wall Street Analysts Are Bullish on Top Healthcare Picks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPSjN2bE1fTHVBQUFtQnozZG1HeTdzNzFyYW9ON0RjcERHOGM0TE13MTBSZFJqajF2RHJPTnVWcXJWc0ROX25rSWhpQ2s4WW9ZcXRHZF9QZzZKQkZqcEJZT2JrdUVyLWxRRW4tNEJTNXdFdnc4eWdGSjlVSm5DQ2xyWGNFYVNxMTh0MWFsSDlydXRxcm5hdGVRVDhPalhLLWZwZ3pDUlZn?oc=5","date":"2026-03-17","type":"deal","source":"The Motley Fool","summary":"Best CRISPR Companies to Buy in 2026 and How to Invest in Them - The Motley Fool","headline":"Best CRISPR Companies to Buy in 2026 and How to Invest in Them","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQXzZrcFdWMTdHQXdQYWRZWG11ZGtpMjZ0dUlwN05Yb0dwalN1ai1LYWZzcVZHT0tNU0FnNzVhcWJ0QlljRl9zYlA1MVNLMUlKc2NsMUt2azRqcWRLQ3NkdWVnZ195REdKV1h0R1BJWkpNSFNCSWRtNF8zZGtXM0ROQUxwUXhnOWEtN3VCQ0VFanozNHlxYW9TMFp6N0VGUQ?oc=5","date":"2026-02-27","type":"pipeline","source":"seekingalpha.com","summary":"Beam Therapeutics: Great Potential, But Patience Is Needed (NASDAQ:BEAM) - seekingalpha.com","headline":"Beam Therapeutics: Great Potential, But Patience Is Needed (NASDAQ:BEAM)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1vN0ZSV0Y5Nnd2a1NBZVZSeFZNZU1Uakstamd3eDhnZjVkRG84cWlPRGphRm5UTnYyNWd0cDhmTVJZMHNnTDNSQVduRHFqeVF0WnBIdDNJN1JwMDVOaWRyWlBuRkpyOFd5Tl84M2VIYlNvZHlfSGFLRQ?oc=5","date":"2026-02-27","type":"deal","source":"U.S. News Money","summary":"7 Top Gene-Editing Stocks to Buy - U.S. News Money","headline":"7 Top Gene-Editing Stocks to Buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOcFZZRklodmRSaWpkaDBMQlhPcTJuYlJyX2NTVnVWdHBibjJwalJYQXdQUnZUYmJSVnZNd3dvREZFUjZZOVZsdDJkM2M1NjVEeTN1YkwzZ2kwMDRabEEzS0FySEVTMTJITWFlOVVxc0dEWnlPczBKMTc2UlptMlhKZmc0dHI5NTJoUHYzUEU5a1RkRnZURTFyd243UXJTWEVhTEd5eXFrYS1KaFI0Nl9lTU53enhFRlBLenE4R25ONmMtRGpCb3NqbHBZZw?oc=5","date":"2026-02-24","type":"pipeline","source":"Sixth Street","summary":"Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street - Sixth Street","headline":"Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxOM2VVcGliU1h5QV9YakJMVzFnRkhqVG5yUzBiLUNqYzg3UXZ1bFlWSlBON3NQVVpaOVNMM2FmbFNuWFRvLWpiemU1bU03Snd4LUN3NkFBT050dnZoUW5uNEI0YlA2dEs1NUo1cGJyamx2WHZPMHBIYVF3OHlQN0ZSdU93VW9JWjJOcU9PS0N3SGJTUkM0R1RqZ1o4alM2ME5ReDdsbmR3b3ZRU1hOMDAzRjVDNDJpRFF4TEIyMkNYVGU0ODRUczZQUlNHSUhFQUFMN2xuN3IwVzhMOUgtb2pONF9PVUFVRzkxdk5CcmpB?oc=5","date":"2025-12-08","type":"pipeline","source":"Citeline News & Insights","summary":"ASH: Beam Can Rival Vertex In Sickle Cell But Bulsufan Deaths Cast A Shadow - Citeline News & Insights","headline":"ASH: Beam Can Rival Vertex In Sickle Cell But Bulsufan Deaths Cast A Shadow - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQZHc5dUUtQmpoakRmVUV5OUFrS2tXWXJpcDdndmpvZl9RcFdUc29feGNUN2lIT1I2QUJVRFdNbXE3aEpMcVhhRHdaaWtZdkktaFFfTEpfUGQ0ZWdmWC1pdmVyWWZWcFpxTmprU2xYTUEzOUlnLWYyQmNRYmI4RUFieXhWMEk1dFVNWlMzVlNET2pBczJMMnJfYjFhdHc?oc=5","date":"2025-11-21","type":"deal","source":"finviz.com","summary":"NTLA Declines 67% in a Month: Should You Buy, Sell or Hold the Stock? - finviz.com","headline":"NTLA Declines 67% in a Month: Should You Buy, Sell or Hold the Stock?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPN2Q4bUd5RWFzeTV1ZXdXRHo2aVBqd3RoRFRBeF91MUR2aWNNdWRTbkwwZ3d1cFdka0JzWTNGS01NQ3RXZVAtaG9WRnV4QnFDQWswRTdrZENyQVdXSTJxWS1EZ0tDWVVyLXhaRklQeHhUQmpsbTZaNUlCNzgteWxuSXNVZmJlMW1MRkRsODlFNFdBNDluUDZJdDZtdUZjblNzcDk2RHJxR29xZw?oc=5","date":"2025-11-04","type":"pipeline","source":"BioSpace","summary":"BioSpace 2026 Best Places to Work Spotlights Most Desirable Workplaces - BioSpace","headline":"BioSpace 2026 Best Places to Work Spotlights Most Desirable Workplaces","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNQ0VXUmt5SU4xd0o5NVdMMWZXVk1LRDlTUXo5SHQ1bVJqdS1IVUFibEp6R2FwRkZWUGlFby1jclhjSy1lczQ3NFl4ckh1Vlo2QV8zQjl0U1FyMUFEbFRqb3ZpQ3B3cF9PQjlMeEUxLVJFcHJxTXFLWTd1dTlOVTQzUW9CaFVxaTBkbXhSaWRfaGdCZ3ZPWExZ?oc=5","date":"2025-10-10","type":"deal","source":"The Business Journals","summary":"Bristol Myers Squibb buys Cambridge biotech for $1.5B - The Business Journals","headline":"Bristol Myers Squibb buys Cambridge biotech for $1.5B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPM1pvYzRNOXJ1M1c5OEZtakNjSlpkVkYtS1FQUmFicUQxdElUUXpHeXJyTG1vN3NfMjZWcmNPcmFZRnJXdmVTaFo0ZjlCeTl3M1RyV1dPRS16bm1OZ3ZHemNCSm9tdlBHNlFoUVR2WnV2TVZ5cjNoRndxaDRFQmZWbmdnNWk2c21oN2NnUHNoMnp3SkRuZlFKbmN4Q0I?oc=5","date":"2025-10-10","type":"deal","source":"C&EN","summary":"Bristol Myers Squibb to buy RNA start-up for $1.5 billion - C&EN","headline":"Bristol Myers Squibb to buy RNA start-up for $1.5 billion - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxOSGZaM19GR05Hdy1yY3lTS1ZGMDY2UThXSWx2LVVhUWh0N2xYTnYwdXNFU0wxRHo3alQ1T1hDZWdYZWZsbVliSXM1YXNzekprTEZPcnF3U3lYUS1aYzYwdlZ0SEprLWlFWE5vb3poZVo0ZWJnOW4zWmJHcWZYYmRyX05KdS05S0liUjJ6dGcyenBrNktkdWtWZS1BbUd1VGVNb21CYWpPWk9qc0JScHVrUzNPN1hZbVlzUUpycmxyWWtoWHc1ZDZCSU1mN1k3RExjM3BQdUthOFNiQTRxYUVVZzBLSUY1S2toR05uSjQ1U0NNVGNxNXM5WkN1cldVTWZ2dDJ3S2lOYWs3bzJHNU9lVDBWYXBzU0tF?oc=5","date":"2025-10-02","type":"trial","source":"GlobeNewswire","summary":"CRISPR Therapies Clinical Trial Pipeline Shows Potential - GlobeNewswire","headline":"CRISPR Therapies Clinical Trial Pipeline Shows Potential","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}